CRISPR Therapeutics (US New England)
With its ground-breaking gene-editing platform CRISPR/Cas9, CRISPR Therapeutics is working to advance breakthrough gene-based therapies for the treatment of hemoglobinopathies, diabetes and cancer.
Product: JMP Live
Amount: $117,000
Integral players: Josh Staunton, Keith Blake, Christian Stopp, Dieter Pisot
